Literature DB >> 32893454

Multifaceted HIV-1 Vif interactions with human E3 ubiquitin ligase and APOBEC3s.

Yingxia Hu1, Kirsten M Knecht1, Qi Shen1, Yong Xiong1.   

Abstract

APOBEC3 (A3) proteins are a family of host antiviral restriction factors that potently inhibit various retroviral infections, including human immunodeficiency virus (HIV)-1. To overcome this restriction, HIV-1 virion infectivity factor (Vif) recruits the cellular cofactor CBFβ to assist in targeting A3 proteins to a host E3 ligase complex for polyubiquitination and subsequent proteasomal degradation. Intervention of the Vif-A3 interactions could be a promising therapeutic strategy to facilitate A3-mediated suppression of HIV-1 in patients. In this structural snapshot, we review the structural features of the recently determined structure of human A3F in complex with HIV-1 Vif and its cofactor CBFβ, discuss insights into the molecular principles of Vif-A3 interplay during the arms race between the virus and host, and highlight the therapeutic implications.
© 2020 Federation of European Biochemical Societies.

Entities:  

Keywords:  APOBEC3; E3 ligase complex; HIV-1 Vif; cryo-EM; virus-host interaction

Year:  2020        PMID: 32893454      PMCID: PMC8172064          DOI: 10.1111/febs.15550

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  100 in total

1.  Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome.

Authors:  Qin Yu; Renate König; Satish Pillai; Kristopher Chiles; Mary Kearney; Sarah Palmer; Douglas Richman; John M Coffin; Nathaniel R Landau
Journal:  Nat Struct Mol Biol       Date:  2004-04-18       Impact factor: 15.369

2.  T-cell differentiation factor CBF-β regulates HIV-1 Vif-mediated evasion of host restriction.

Authors:  Wenyan Zhang; Juan Du; Sean L Evans; Yunkai Yu; Xiao-Fang Yu
Journal:  Nature       Date:  2011-12-21       Impact factor: 49.962

3.  Structural Insights into HIV-1 Vif-APOBEC3F Interaction.

Authors:  Masaaki Nakashima; Hirotaka Ode; Takashi Kawamura; Shingo Kitamura; Yuriko Naganawa; Hiroaki Awazu; Shinya Tsuzuki; Kazuhiro Matsuoka; Michiko Nemoto; Atsuko Hachiya; Wataru Sugiura; Yoshiyuki Yokomaku; Nobuhisa Watanabe; Yasumasa Iwatani
Journal:  J Virol       Date:  2015-11-04       Impact factor: 5.103

4.  Structural basis for hijacking CBF-β and CUL5 E3 ligase complex by HIV-1 Vif.

Authors:  Yingying Guo; Liyong Dong; Xiaolin Qiu; Yishu Wang; Bailing Zhang; Hongnan Liu; You Yu; Yi Zang; Maojun Yang; Zhiwei Huang
Journal:  Nature       Date:  2014-01-09       Impact factor: 49.962

5.  Multifaceted counter-APOBEC3G mechanisms employed by HIV-1 Vif.

Authors:  Elena Britan-Rosich; Roni Nowarski; Moshe Kotler
Journal:  J Mol Biol       Date:  2011-07-29       Impact factor: 5.469

6.  Differential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F.

Authors:  Chunjuan Tian; Xianghui Yu; Wei Zhang; Tao Wang; Rongzhen Xu; Xiao-Fang Yu
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

7.  Structural insight into the human immunodeficiency virus Vif SOCS box and its role in human E3 ubiquitin ligase assembly.

Authors:  Bradford J Stanley; Elana S Ehrlich; Leslie Short; Yunkai Yu; Zuoxiang Xiao; Xiao-Fang Yu; Yong Xiong
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

8.  A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor.

Authors:  Hal P Bogerd; Brian P Doehle; Heather L Wiegand; Bryan R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-03       Impact factor: 11.205

9.  Identification of amino acid residues in APOBEC3G required for regulation by human immunodeficiency virus type 1 Vif and Virion encapsidation.

Authors:  Hendrik Huthoff; Michael H Malim
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

10.  Distinct determinants in HIV-1 Vif and human APOBEC3 proteins are required for the suppression of diverse host anti-viral proteins.

Authors:  Wenyan Zhang; Gongying Chen; Anna Maria Niewiadomska; Rongzhen Xu; Xiao-Fang Yu
Journal:  PLoS One       Date:  2008-12-17       Impact factor: 3.240

View more
  5 in total

1.  Divergence in Dimerization and Activity of Primate APOBEC3C.

Authors:  Amit Gaba; Mark A Hix; Sana Suhail; Ben Flath; Brock Boysan; Danielle R Williams; Tomas Pelletier; Michael Emerman; Faruck Morcos; G Andrés Cisneros; Linda Chelico
Journal:  J Mol Biol       Date:  2021-10-16       Impact factor: 6.151

2.  Cryo-EM structure of the EBV ribonucleotide reductase BORF2 and mechanism of APOBEC3B inhibition.

Authors:  Nadine M Shaban; Rui Yan; Ke Shi; Sofia N Moraes; Adam Z Cheng; Michael A Carpenter; Jason S McLellan; Zhiheng Yu; Reuben S Harris
Journal:  Sci Adv       Date:  2022-04-27       Impact factor: 14.957

Review 3.  Degradation-Independent Inhibition of APOBEC3G by the HIV-1 Vif Protein.

Authors:  Benjamin Stupfler; Cédric Verriez; Sarah Gallois-Montbrun; Roland Marquet; Jean-Christophe Paillart
Journal:  Viruses       Date:  2021-04-03       Impact factor: 5.048

Review 4.  Examination of the APOBEC3 Barrier to Cross Species Transmission of Primate Lentiviruses.

Authors:  Amit Gaba; Ben Flath; Linda Chelico
Journal:  Viruses       Date:  2021-06-07       Impact factor: 5.048

Review 5.  Foamy Viruses, Bet, and APOBEC3 Restriction.

Authors:  Ananda Ayyappan Jaguva Vasudevan; Daniel Becker; Tom Luedde; Holger Gohlke; Carsten Münk
Journal:  Viruses       Date:  2021-03-18       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.